No coronavirus-related drug shortages yet, says EMA

The European Medicines Agency (EMA) has said that no drug shortages or supply disruptions due to the coronavirus outbreak have been reported, but that a steering group has convened to address the epidemic’s impact on the supply of medicines in the EU.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

FDA reveals COVID-19-related drug shortage

2 March 2020 The US Food and Drug Administration has revealed a COVID-19-related shortage of a drug, adding to concerns that the virus has the potential to massively disrupt medical supply chains.

Americas

Fortress offers licences after COVID-19 testing patent backlash

19 March 2020 Labrador Diagnostics, a subsidiary of Fortress Investment Group, has offered royalty-free licences to third parties for its patent-protected diagnostics technology, just days after suing US-based health startup BioFire, which is attempting to develop COVID-19 testing kits.

Big Pharma

Bad news for Italy’s EMA relocation challenge

15 July 2022 EU’s top court denies bid that Amsterdam decision was a “misuse of powers” | Complaint said The Netherlands facility wasn’t ready | Milan lost out after random pick from a fish bowl.

More on this story

Big Pharma

FDA reveals COVID-19-related drug shortage

2 March 2020 The US Food and Drug Administration has revealed a COVID-19-related shortage of a drug, adding to concerns that the virus has the potential to massively disrupt medical supply chains.

Americas

Fortress offers licences after COVID-19 testing patent backlash

Big Pharma

Bad news for Italy’s EMA relocation challenge

More on this story

Big Pharma

FDA reveals COVID-19-related drug shortage

2 March 2020 The US Food and Drug Administration has revealed a COVID-19-related shortage of a drug, adding to concerns that the virus has the potential to massively disrupt medical supply chains.

Americas

Fortress offers licences after COVID-19 testing patent backlash

Big Pharma

Bad news for Italy’s EMA relocation challenge